Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (Results from the GUSTO-III trial)

American Journal of Cardiology

Volumn 84, Issue 7, 1999, Pages 779-784

  Miller, Julie M ^a   Smalling, Richard ^b   Ohman, E Magnus ^a   Bode, Christoph ^c   Betriu, Amadeo ^d   Kleiman, Neal S ^e   Schildcrout, Jonathan S ^a   Bastos, Eugenia ^a   Topol, Eric J ^f   Califf, Robert M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b MEMORIAL HERMANN HOSPITAL   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HOSPITAL CLÍNIC   (Spain)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN; RETEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT FAILURE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032887115     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00437-3     Document Type: Article

References (13)

1. Davies C.H., Ormerod O.J.M. Failed coronary thrombolysis. Lancet. 351:1998;1191-1196.
2. Ellis S.G., da Silva E.R., Heyndrickx G., Talley J.D., Cernigliaro C., Steg G., Spaulding C., Nobuyoshi M., Erbel R., Vassanelli C. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 90:1994;2280-2284.
3. Ohman E.M., Califf R.M., Topol E.J., Candela R., Abbottsmith C., Ellis S., Sigmon K.N., Kereiakes D., George B., Stack R. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 82:1990;781-791.
4. Califf R.M., Topol E.J., George B.S., Boswick J.M., Lee K.L., Stump D., Dillon J., Abbottsmith C., Candela R.J., Kereiakes D.J. Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial . Circulation. 77:1988;1090-1099.
5. Lefkovits J., Ivanhoe R.J., Califf R.M., Bergelson B.A., Anderson K.M., Stoner G.L., Weisman H.F., Topol E.J. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abcix-imab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 77:1996;1045-1051.
6. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation. 96:1997;1445-1453.
7. Brener S.J., Barr L.A., Burchenal J.E.B., Katz S., George B.S., Jones A.A., Cohen E.D., Gainey P.C., White H.J., Cheek H.B., Moses J.W., Moliterno D.J., Effron M.B., Topol E.J. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 98:1998;734-741.
8. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 337:1997;1118-1123.
9. Randomized comparison of four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
10. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I a comparison between intravenous tissue plasminogen activator and intravenous streptokinase . Circulation. 76:1987;142-154.
11. Barsness G.W., Ohman E.M., Thompson T.D., Sketch M.H. Jr, Holmes D.R. Jr, Califf R.M. Early hazard of "rescue" angioplasty after thrombolysis is reduced by improved long-term outcome. J Am Coll Cardiol. 29:(suppl A):1997;71A.
12. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
13. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696.